Description
Fc Engineered Anti-Human GD2 Antibody, CDC-Enhanced (BioBet-C019ZP) is a recombinant monoclonal Whole Chimeric antibody against GD2. This product is a CDC enhanced antibody produced by our proprietary platform.
Indication
Severe Eosinophilic Asthma
Severe nasal polyposis
Adult patients with eosinophilic granulomatosis
Classification
Therapeutic antibody; biobetter
Cooperation Seeking
Creative Biolabs is interested in collaborating with potential partners (include but not limit to major pharma or biotech firms) to further co-develop ADCC-enhanced Dinutuximab. For commercial partners interested in our ADCC-enhanced therapeutic antibodies, Creative Biolabs welcomes collaboration. Here are two ways for your choice, and please contact us for more details.
1) Collaborate with us and co-develop the programs from discovery phase to IND enabling. Costs will be shared.
2) Become a licensed candidate of our programs.
Looking forward to cooperating with you in the near future.
Official Name
GD2
Full Name
Disialoganglioside GD2
Biologic Classification
Protein Based Therapies
Monoclonal antibody (mAb)
Antibody Isotype
Chimeric IgG1
Indication
High Risk Neuroblastoma
Melanoma
High Risk Neuroblastoma
Melanoma
